PubMed · 7691615
Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.
Abstract
The 20 kDa homologous restriction factor (HRF20, CD59) prevents formation of membrane attack complexes of human complement. Transfection of the cDNA of HRF20 to heterologous cells, which are sensitive to human complement, thereby renders these cells resistant to human complement attack. This property can then be used as a selection marker of transfection. In addition, the procedure is short and can be performed within 8 h. Since only 1 h is required for incubation with complement, the damage to the transfected cells is limited compared with damage resulting from selection for drug resistance which requires 10 days or more of incubation in the presence of harmful agents.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H Takizawa, K Takahashi, T Murakami, N Okada, H Okada. 1993. Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.. https://doi.org/10.1002/eji.1830231052
Cite the original work for its findings. Save a collection to share your selection of sources.